181.79

0.99% 1.78

Align Technology Inc (ALGN)

Overview News Price History Option Chain Financials Why ALGN Down? Discussions Forecast

Align Technology Inc stock is traded at $181.79, with a volume of 1.28M. It is up +0.99% in the last 24 hours and down -0.43% over the past month. Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

Previous Close:

$180.01

Open:

$182.22

24h Volume:

1.28M

Relative Volume:

1.17

Market Cap:

$13.63B

Revenue:

$3.98B

Net Income/Loss:

$409.56M

P/E Ratio:

33.11

EPS:

5.49

Net Cash Flow:

$630.74M

1W Performance:

+2.22%

1M Performance:

-0.43%

6M Performance:

-13.87%

1Y Performance:

-25.07%

1-Day Range:

$180.56

$183.97

1-Week Range:

$172.88

$183.97

52-Week Range:

$141.74

$263.24

Align Technology Inc Stock (ALGN) Company Profile

Name

Align Technology Inc

Sector

Healthcare (1174)

Industry

Medical Instruments & Supplies (61)

Phone

408-470-1000

Address

410 NORTH SCOTTSDALE ROAD, SUITE 1300, TEMPE, CA

Employee

21,200

Twitter

@AlignTechInc

Next Earnings Date

2024-10-23

Latest SEC Filings

ALGN's Discussions on Twitter

Compare ALGN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ALGN Align Technology Inc	181.79	13.63B	3.98B	409.56M	630.74M	5.49
ISRG Intuitive Surgical Inc	509.36	189.82B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	168.42	49.98B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	85.40	44.00B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	253.68	37.05B	5.02B	1.31B	1.56B	8.91
WST West Pharmaceutical Services Inc	215.82	16.36B	2.90B	467.20M	306.90M	6.37

Align Technology Inc Stock (ALGN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-25-25	Downgrade	HSBC Securities	Buy → Hold
Feb-14-25	Initiated	Wells Fargo	Overweight
Jan-06-25	Upgrade	Leerink Partners	Market Perform → Outperform
Dec-04-24	Initiated	Mizuho	Outperform
Oct-10-24	Initiated	Needham	Hold
Feb-26-24	Initiated	Leerink Partners	Market Perform
Dec-11-23	Downgrade	Goldman	Neutral → Sell
Oct-27-23	Downgrade	UBS	Buy → Neutral
Feb-02-23	Upgrade	Goldman	Sell → Neutral
Jul-28-22	Downgrade	Goldman	Buy → Sell
Jan-31-22	Initiated	Morgan Stanley	Overweight
Jan-31-22	Upgrade	UBS	Neutral → Buy
Oct-01-21	Resumed	Credit Suisse	Outperform
Aug-05-21	Resumed	Credit Suisse	Outperform
Jul-09-21	Upgrade	Stephens	Equal-Weight → Overweight
Jul-08-21	Initiated	Exane BNP Paribas	Outperform
Apr-22-21	Upgrade	Berenberg	Hold → Buy
Jan-04-21	Upgrade	Evercore ISI	In-line → Outperform
Jul-29-20	Downgrade	Berenberg	Buy → Hold
Jul-20-20	Downgrade	BofA Securities	Neutral → Underperform
Jan-09-20	Upgrade	Wolfe Research	Peer Perform → Outperform
Oct-24-19	Reiterated	BofA/Merrill	Neutral
Oct-07-19	Downgrade	Guggenheim	Buy → Neutral
Jul-25-19	Downgrade	Evercore ISI	Outperform → In-line
May-30-19	Initiated	Wolfe Research	Peer Perform
Apr-18-19	Initiated	Guggenheim	Buy
Feb-14-19	Downgrade	UBS	Buy → Neutral
Jan-17-19	Initiated	UBS	Buy
Nov-20-18	Reiterated	Credit Suisse	Outperform
Jul-26-18	Reiterated	Stifel	Buy
Jul-13-18	Reiterated	Stifel	Buy
Jun-25-18	Resumed	BofA/Merrill	Buy
May-22-18	Reiterated	Stifel	Buy
May-17-18	Initiated	Evercore ISI	Outperform
Apr-26-18	Reiterated	Stifel	Buy
Apr-20-18	Initiated	Berenberg	Buy
Apr-19-18	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Mar-08-18	Initiated	Barclays	Overweight

View All

Align Technology Inc Stock (ALGN) Latest News

Jun 18, 2025